However, in breast cancer cells, whether SRPK1 can indeed be acetylated, whether the acetylation is mediated by Tip60 and whether this novel PTM of SRPK1 could lead to cisplatin resistance remain unknown. This evidence concerns the gene KAT5 and breast carcinoma.